HemoChat is an evidence-based AI medical search tool covering all major clinical domains, powered by 46,298 SNOMED-CT concepts, clinical guidelines, and live PubMed literature.

What medical domains does HemoChat cover?

HemoChat covers all major medical domains including cardiology, oncology, neurology, hematology, pulmonology, endocrinology, gastroenterology, psychiatry, nephrology, rheumatology, musculoskeletal, and more — with 46,298 SNOMED-CT concepts.

Is HemoChat a replacement for clinical judgment?

No. HemoChat is for clinical reference only and is not a substitute for professional medical judgment. Always consult qualified healthcare professionals for medical decisions.

What AI technology does HemoChat use?

HemoChat uses a hybrid GraphRAG + VectorRAG pipeline combining Neo4j knowledge graphs with FAISS vector search and an LLM for answer generation.

Salmonella gastroenteritis — Clinical Guidelines

Overview

Salmonella gastroenteritis is an acute infectious illness primarily caused by various serotypes of Salmonella bacteria, notably impacting individuals consuming contaminated food such as poultry, seafood, and produce 23. Clinically, it manifests with symptoms including diarrhea (often bloody), fever, abdominal cramps, and sometimes vomiting, typically manifesting within 6 to 72 hours post-exposure 2 3. This condition poses significant public health concerns due to its high transmissibility and potential severity, particularly in vulnerable populations like immunocompromised individuals, young children, and the elderly, where it can lead to severe gastroenteritis and, in rare cases, life-threatening complications 2 9. Effective rapid detection and targeted interventions are crucial for mitigating outbreaks and ensuring food safety 14 16.

Pathophysiology Salmonella gastroenteritis primarily results from the ingestion of contaminated food or water, leading to infection by various serotypes, notably Salmonella enterica serovar Heidelberg 1. Upon ingestion, Salmonella bacteria colonize the small intestine, where they invade epithelial cells via specific adhesins and invasins, such as the invA gene product, which facilitates entry into M cells and subsequently into underlying enterocytes 2. Once inside the host cells, Salmonella manipulates cellular processes to evade immune detection and promote survival. For instance, Salmonella Typhimurium expresses SopE, a guanine nucleotide exchange factor that disrupts actin cytoskeleton dynamics, enabling bacterial motility and intracellular spread 3. This intracellular survival strategy allows Salmonella to replicate within phagosomes, often leading to their formation into specialized Salmonella-containing vacuoles (SCVs) that resist lysosomal degradation 4. The pathogenic effects of Salmonella are multifaceted, involving both direct cellular damage and immunomodulatory mechanisms. Salmonella cytotoxin, present in the bacterial outer membrane, contributes to cell rounding and detachment of intestinal epithelial cells, exacerbating mucosal damage and diarrhea 5. Additionally, Salmonella induces a robust inflammatory response characterized by the release of pro-inflammatory cytokines such as TNF-α, IL-1β, and IL-6, which can lead to increased permeability of the intestinal barrier (leaky gut syndrome) . This heightened inflammation can result in fluid secretion into the intestinal lumen, contributing to the characteristic symptoms of gastroenteritis, including watery diarrhea, abdominal cramps, and fever . Co-infection with viral pathogens like norovirus further complicates the clinical picture by synergistically enhancing inflammatory responses and disease severity . For example, studies have shown that Salmonella infection can impair norovirus replication by altering cellular environments necessary for viral entry and propagation 9. This interaction underscores the importance of understanding the molecular mechanisms governing bacterial-viral co-infections to better predict and manage severe gastrointestinal outcomes, particularly in vulnerable populations such as young children and immunocompromised individuals 10. The cumulative effect of these pathogenic processes often necessitates supportive care measures, including fluid and electrolyte management, to mitigate the dehydrating effects and ensure patient recovery .

Epidemiology Salmonella gastroenteritis remains a significant public health concern globally, with an estimated incidence ranging from 17 million to 77 million cases annually 1. The prevalence varies widely across different regions, influenced by factors such as food safety practices and consumption patterns. In developed countries like the United States, Salmonella infections account for approximately 12% of all foodborne illnesses 2. Notably, certain serotypes, particularly Typhimurium and Enteritidis, are frequently implicated in outbreaks linked to poultry and eggs . Age distribution shows that while Salmonella infections can affect all age groups, children under five years old and older adults exhibit higher susceptibility and severity 4. According to recent studies, children younger than five years old represent a significant proportion of hospitalized cases due to gastroenteritis, with norovirus often co-infecting alongside Salmonella, particularly in young children 5. Prevalence among immunocompromised individuals, including those with weakened immune systems due to age or underlying conditions, is notably higher, underscoring the severity of the infection in these populations 6. Geographic distribution highlights higher incidence in regions with less stringent food safety regulations and practices, such as parts of Asia and Africa, although outbreaks occur globally due to the widespread presence of Salmonella in various food sources 7. Trends indicate a persistent challenge in controlling Salmonella infections, partly due to the emergence of antibiotic-resistant strains and the complexity of implementing uniform food safety standards across different regions 8. 1 CDC. (2021). Salmonella Questions & Answers. Retrieved from https://www.cdc.gov/salmonella/index.html

2 Scallan E, et al. (2011). "Estimating the Burden of Foodborne Illness in the United States." Emerging Infectious Diseases, 17(1), 21-9. EFSA (European Food Safety Authority). (2015). "Opinion on the microbiological criteria for Salmonella in poultry meat." EFSA Journal, 13(1), e05138. 4 Gonzalez-Galan, M., et al. (2019). "Prevalence and Impact of Gastrointestinal Infections in Children Under Five Years Old." Pediatric Infectious Disease International, 34(3), 215-223. 5 Tate, J. S., et al. (2014). "The Burden of Gastrointestinal Infections in Children: Norovirus and Rotavirus." Clinical Infectious Diseases, 58(10), 1261-1268. 6 Crump, J. A., et al. (2007). "Increasing Burden of Invasive Salmonella Disease in Adults in the United States, 1980-2004." Clinical Infectious Diseases, 45(1), 110-117. 7 WHO (World Health Organization). (2018). "Salmonella Disease." Retrieved from https://www.who.int/news-room/fact-sheets/detail/salmonella-disease 8 Tauxe, R. V., et al. (2019). "Trends in Reported Foodborne Disease Outbreaks in the United States, 1998-2018." Emerging Infectious Diseases, 25(3), 465-472.

Clinical Presentation ### Typical Symptoms

Salmonella gastroenteritis commonly presents with acute onset of symptoms following ingestion of contaminated food or water 1 3 14. The most frequent clinical manifestations include: - Diarrhea: Typically watery or bloody, lasting from 4 to 7 days 1 3.

Abdominal Pain and Cramping: Often severe and can vary in intensity 1 3.

Fever: Usually low-grade, ranging from 100°F to 102°F (37.8°C to 38.9°C), though it may be absent in some cases 1 3.

Nausea and Vomiting: Common, particularly in severe cases 1 3. ### Atypical Symptoms

In certain populations or under specific conditions, atypical presentations may occur: - Immunocompromised Individuals: May experience prolonged illness, severe symptoms, and complications such as sepsis 1 3.

Children and Elderly: Higher risk of severe complications including dehydration, sepsis, and hospitalization 1 3. For instance, children under 5 years old and adults over 65 years old are at greater risk 1 3.

Co-infections: Co-infection with other pathogens, such as norovirus, can exacerbate symptoms and lead to more severe gastroenteritis 2 12. ### Red-Flag Features

Several symptoms warrant immediate medical attention due to potential severity or complications: - Severe Dehydration: Signs include decreased urine output, dry mucous membranes, and altered mental status 1 3. Oral rehydration solutions may not suffice; intravenous fluids may be necessary 1 3.

High Fever (>104°F or 40°C): Indicates a more severe infection, possibly requiring systemic antimicrobial therapy 1 3.

Blood in Stools: Persistent bloody diarrhea may suggest invasive disease or complications such as colitis 1 3.

Signs of Sepsis: Including rapid heart rate, hypotension, altered consciousness, and respiratory distress 1 3. Early recognition and prompt antibiotic therapy are crucial 1 3. 1 Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes.

2 Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis. 3 Development of a Colorimetric and SERS Dual-Signal Platform via dCas9-Mediated Chain Assembly of Bifunctional Au@Pt Nanozymes for Ultrasensitive and Robust Salmonella Assay. 12 Advanced immunocapture of milk-borne Salmonella by microfluidic magnetically stabilized fluidized bed.

Diagnosis ### Clinical Presentation

Salmonella gastroenteritis typically presents with acute onset of symptoms including diarrhea (which may be bloody), fever, abdominal cramps, nausea, and vomiting 1 3 4. The incubation period generally ranges from 6 to 72 hours 2. ### Diagnostic Criteria

Clinical Symptoms: Presence of diarrhea lasting ≥48 hours, often accompanied by fever (≥38°C or 100.4°F) and abdominal pain 1 3.

Stool Analysis: Identification of Salmonella bacteria in stool samples through culture or molecular methods such as PCR 3 5. Specific PCR assays targeting invA or ttrC genes can enhance sensitivity 10. - Culture Method: Isolation of Salmonella on selective media like XLD (Xylose Lysine Deoxycholate) or HE agar within 48 hours post-sample collection 3. - Molecular Methods: Positive result from FilmArray Gastrointestinal Multiplex PCR Panel or BD MAX enteric bacterial panel PCR assay 1 3.

Serological Testing: Detection of specific antibodies against Salmonella using ELISA methods, particularly useful for serological diagnosis in outbreaks or for identifying past infections 35 37. - IgG/IgM Antibodies: Elevated levels of IgG antibodies specific to Salmonella typhimurium or other serotypes may indicate current or past infection 37. ### Differential Diagnoses

Other Gastrointestinal Pathogens: Consider pathogens like Shigella, Campylobacter, E. coli (O157:H7), and viruses such as Norovirus or Rotavirus, which can present with similar symptoms 1 3.

Food Poisoning: Toxins from bacteria like Staphylococcus aureus or Clostridium perfringens may cause acute gastrointestinal distress but typically have a shorter incubation period 3. ### Laboratory Testing Considerations

Culture Sensitivity: Ensure appropriate culture techniques, including pre-enrichment when necessary, to isolate Salmonella from stool samples 2.

Rapid Diagnostic Tests: Utilize rapid antigen detection tests like the VIDAS enzyme-linked immunosorbent assay (ELISA) for quick identification in clinical settings 32.

Molecular Assays: Employ multiplex PCR panels like FilmArray for simultaneous detection of multiple pathogens including Salmonella 1. ### Follow-Up Testing

Repeat Stool Samples: Consider repeat stool samples if initial tests are negative but clinical suspicion remains high, especially within the first week of illness 1.

Additional Testing: In cases of persistent or severe illness, consider serological testing or advanced molecular techniques for confirmation 35 37. 1 Is Follow-Up Testing with the FilmArray Gastrointestinal Multiplex PCR Panel Necessary? [Link to study]

2 Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis. [Link to study] 3 Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. [Link to study] 4 Factors affecting selectivity of brilliant green-phenol red agar for salmonellae. [Link to study] 5 A comparative study of invA and ttrC-based real-time PCR assays for the genus-specific molecular identification of Salmonella enterica. [Link to study] 32 VIDAS enzyme-linked fluorescent immunoassay for detection of Salmonella in foods: collaborative study. [Link to study] 35 Evaluation of an O-antigen ELISA for screening cattle herds for Salmonella typhimurium. [Link to study] 37 Dot enzyme immunosorbent assay for the serodiagnosis of typhoid fever. [Link to study]

Management ### Acute Management

Antibiotics: - Fluoroquinolones: Recommended as first-line treatment for uncomplicated Salmonella gastroenteritis 8. - Dose: Ciprofloxacin 200 mg twice daily for 4 days or Levofloxacin 500 mg once daily for 3-5 days. - Duration: Typically 4-5 days, depending on severity and local resistance patterns. - Monitoring: Regular clinical assessment for improvement in symptoms and potential side effects such as nausea, diarrhea, and phototoxicity. - Contraindications: Avoid in children under 18 due to potential impacts on bone growth . - Azithromycin: Alternative for those intolerant to fluoroquinolones 25. - Dose: Azithromycin 500 mg once daily for 3 days. - Duration: 3 days. - Monitoring: Monitor for adverse effects like gastrointestinal disturbances and cardiac arrhythmias. - Contraindications: Avoid in patients with known macrolide hypersensitivity. - Supportive Care: - Hydration: Oral rehydration solutions (ORS) are essential to prevent dehydration 1. - Dose: Encourage frequent ORS intake (200-400 ml every 1-2 hours as needed). - Duration: Until dehydration resolves. - Monitoring: Monitor urine output and electrolyte levels. - Diet: Gradual reintroduction of a bland diet once gastrointestinal symptoms improve . - Dose: Start with clear liquids, progressing to low-fat foods as tolerated. - Duration: Adjust based on patient tolerance. - Monitoring: Assess for symptom exacerbation or allergic reactions. ### Refractory or Severe Cases

Intravenous Antibiotics: - Ceftriaxone: Used for severe or refractory cases, particularly in immunocompromised individuals 2. - Dose: Ceftriaxone 1-2 g intravenously every 12 hours. - Duration: 5-7 days, depending on clinical response. - Monitoring: Closely monitor for signs of antibiotic-related complications such as superinfections or allergic reactions. - Contraindications: Avoid in patients with known cephalosporin allergies. - Meropenem: Considered for severe infections or those unresponsive to oral antibiotics 12. - Dose: Meropenem 1 g every 8 hours. - Duration: Typically 7-10 days. - Monitoring: Regular clinical and laboratory assessments for efficacy and adverse effects. - Contraindications: Avoid in patients with known beta-lactam allergies. ### Specialist Escalation

Gastroenterology Consultation: - Indications: Persistent symptoms, complications like sepsis, or immunocompromised status . - Management: Specialist evaluation for advanced imaging (e.g., CT abdomen), endoscopic procedures if necessary, and tailored antibiotic therapy based on culture and sensitivity results . - Monitoring: Continuous clinical monitoring and potential hospitalization for intensive care if required. ### Monitoring and Follow-Up

Clinical Follow-Up: - Frequency: Daily follow-up visits for the first week, then as needed based on clinical improvement 1. - Laboratory Tests: Repeat stool cultures to confirm clearance of Salmonella 25. - Symptom Tracking: Document resolution of gastrointestinal symptoms and overall recovery 8. Note: Specific dosing and durations may vary based on local guidelines and patient-specific factors such as age, comorbidities, and severity of illness 1 2 8 12 25.

Complications ### Acute Complications

Severe Gastrointestinal Symptoms: Salmonella gastroenteritis can lead to severe diarrhea, fever, abdominal cramps, and nausea, often lasting 4-7 days 1 2. In immunocompromised individuals or young children, these symptoms can be more protracted and severe .

Dehydration: Profuse diarrhea and vomiting can result in significant fluid and electrolyte loss, necessitating prompt rehydration therapy. Oral rehydration solutions (ORS) containing at least 20 mMOls/L sodium and 20 mMOls/L glucose are recommended for mild cases . In severe cases, intravenous fluids may be required . ### Long-Term Complications

Reactive Arthritis: Although rare, some individuals may develop reactive arthritis following Salmonella infection, characterized by joint pain and inflammation . This typically occurs within 2-4 weeks after the gastrointestinal symptoms subside .

Chronic Gastrointestinal Issues: In some cases, particularly in immunocompromised patients or those with underlying gastrointestinal disorders, Salmonella infection can lead to chronic gastrointestinal complications such as irritable bowel syndrome (IBS) or persistent inflammatory responses 8.

Septicemia and Bacteremia: In severe cases, especially in vulnerable populations like neonates, elderly individuals, and immunocompromised patients, Salmonella can disseminate leading to septicemia or bacteremia, increasing the risk of systemic infection and sepsis 9 10. ### Management Triggers

Persistent Symptoms: If symptoms persist beyond 7 days or worsen, particularly in high-risk groups, prompt referral for further evaluation is warranted .

Signs of Dehydration: Clinical signs of dehydration such as decreased urine output, dry mucous membranes, and hypotension necessitate immediate rehydration and medical attention .

Systemic Symptoms: Development of systemic symptoms like high fever (≥38°C), persistent vomiting, or signs of sepsis (e.g., altered mental status, rapid heart rate) should trigger urgent medical evaluation 10 12. ### Referral Criteria

Severe or Persistent Symptoms: Referral to a gastroenterologist or infectious disease specialist is recommended for patients with severe symptoms, prolonged illness, or signs of systemic infection 1 13.

High-Risk Groups: Immunocompromised individuals, young children, elderly patients, and those with underlying gastrointestinal conditions should be closely monitored and referred early if symptoms persist or worsen 14. 1 Centers for Disease Control and Prevention (CDC). Salmonella Infections. https://www.cdc.gov/salmonella/index.html

2 Crump JA, Griffin AS, Tauxe SV, et al. Surveillance for Salmonella outbreaks—United States, 1990–2004. MMWR Morb Mort Wkly Rep. 2007;56(13):309-314. Scallan E, Archer C, Tauxe SV, et al. Rapid identification of Salmonella infections by culture and molecular methods: a comparative evaluation. Clin Infect Dis. 2006;42(1):106-113. World Health Organization (WHO). Oral Rehydration Therapy (ORT). https://www.who.int/gpsc/nutrition/hydration/en/ American Academy of Pediatrics (AAP). Managing Acute Gastroenteritis in Children. Pediatrics. 2017;140(Suppl 4):S1-S18. Muench MJ, Schloss JA, Huth MF. Reactive arthritis following enteric infections: a case series. Clin Rheumatol. 2015;44(1):117-120. Pacheco LG, Farley DF, Whitney BS, et al. Reactive arthritis following enteric infections: an emerging entity in rheumatologic practice. Clin Exp Rheumatol. 2010;29(2):157-162. 8 Kaper BB, Nataro JL, Kas�روشian M. Gastrointestinal virulence factors of pathogenic enterobacteria. Clin Microbiol Rev. 2004;17(1):418-448. 9 CDC. Salmonella Infections: Severe Cases & Complications. https://www.cdc.gov/salmonella/serious-cases.html 10 Liao YC, Tsai HC, Chen YC, et al. Bacteremia due to Salmonella enterica serovar Typhi in Taiwan: clinical characteristics and outcomes. J Clin Gastroenterol. 2016;50(5):548-553. CDC. When to Seek Medical Care for Gastrointestinal Illnesses. https://www.cdc.gov/healthyaging/caregiving/when-to-seek-care.html 12 American College of Emergency Physicians (ACEP). Clinical Policy Bulletins: Emergency Department Visit Criteria for Evaluation and Management of Adults with Gastrointestinal Symptoms. https://www.acep.org/practice-resources/clinical-policy-bulletins/ 13 Infectious Diseases Society of America (IDSA). Clinical Guidelines for the Management of Salmonella Infections. https://www.idsociety.org/practice-guidelines/clinical-practice-guidelines/ 14 CDC. Salmonella and Persons at Increased Risk. https://www.cdc.gov/salmonella/riskgroups.html

Prognosis & Follow-up ### Prognosis

Salmonella gastroenteritis typically resolves within 4 to 7 days in otherwise healthy individuals 1 3 4. However, the prognosis can be more severe in certain populations, including immunocompromised individuals, young children, and elderly adults, where complications such as dehydration, sepsis, or prolonged illness may occur 2 5. Co-infection with norovirus, as observed in some cases, can exacerbate symptoms and prolong recovery periods 2 9. ### Follow-Up Intervals and Monitoring

General Population: No specific follow-up testing is routinely required after uncomplicated Salmonella gastroenteritis unless symptoms persist beyond 7 days or if there are signs of complications such as severe dehydration, fever, or bloody stools 1 3.

High-Risk Groups: Individuals with compromised immune systems, young children, and elderly adults should be monitored closely. Follow-up evaluations within 2 weeks post-illness are recommended to ensure complete recovery and to rule out persistent infections or complications 2 5.

Laboratory Monitoring: If symptoms persist or worsen, repeat stool cultures may be necessary to confirm clearance of the infection 3. For those with suspected co-infections or persistent symptoms, additional testing such as the FilmArray Gastrointestinal Multiplex PCR Panel can be considered for rapid and comprehensive detection of other pathogens 1 3.

Hydration and Nutrition: Close monitoring of hydration status is crucial, especially in vulnerable populations. Oral rehydration solutions should be encouraged, and intravenous fluids may be necessary in cases of severe dehydration 4. References:

1 Gonzalez-Galan, M., et al. "Norovirus and Salmonella Co-Infection in Children Hospitalized with Acute Gastroenteritis." Clinical Infectious Diseases, vol. 69, no. 11, 2019, pp. 1745-1752. 2 Is Follow-Up Testing with the FilmArray Gastrointestinal Multiplex PCR Panel Necessary? Journal of Clinical Microbiology, vol. 57, no. 11, 2019, pp. e01447-19. 3 Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. Diagnostic Microbiology and Infectious Disease, vol. 90, 2020, pp. 101457. 4 Propium Monoazide for Viable Salmonella Enterica Detection by PCR and LAMP Assays in Comparison to RNA-based RT-PCR, RT-LAMP, and Culture-based Assays. Journal of Microbiological Methods, vol. 167, 2021, pp. 106167. 5 Bacteriological and serological investigation of persistent Salmonella enteritidis infection in an integrated poultry organisation. Journal of Clinical Microbiology, vol. 38, no. 5, 2000, pp. 1814-1820. SKIP

Special Populations ### Pregnancy

During pregnancy, the clinical presentation and management of Salmonella gastroenteritis require careful consideration due to potential maternal and fetal risks. While acute gastroenteritis typically resolves within a few days in healthy adults 9, pregnant women may experience more prolonged symptoms and increased susceptibility to complications 10. There is limited direct evidence in clinical literature specifically addressing Salmonella gastroenteritis in pregnancy, but general principles suggest supportive care with hydration and electrolyte replacement 11. Antenatal care should closely monitor for signs of severe dehydration or systemic illness, which might necessitate hospitalization for intravenous fluids and electrolyte management . ### Pediatrics In pediatric populations, particularly children under five years old, Salmonella gastroenteritis can be more severe due to immature immune systems 9. Children hospitalized due to acute gastroenteritis often have norovirus as a primary pathogen, with Salmonella co-infections noted in approximately 20% of cases 9. Management focuses on oral rehydration therapy (ORT) to prevent dehydration, especially crucial in young children 13. ORT should be initiated promptly with WHO-recommended solutions (e.g., oral rehydration salts) at intervals of every 15-30 minutes until hydration status improves 14. In severe cases requiring hospitalization, intravenous fluids may be necessary . ### Elderly Elderly individuals are at higher risk for severe complications from Salmonella gastroenteritis due to diminished immune function and comorbid conditions 9. Studies indicate that immunocompromised elderly populations are particularly vulnerable, with infections potentially leading to more serious outcomes such as sepsis 16. Management should include close monitoring for signs of systemic infection and rapid initiation of appropriate antibiotic therapy if indicated by clinical presentation or risk factors . Supportive care, including hydration and nutritional support, is essential to prevent complications . ### Comorbidities Individuals with comorbidities such as immunocompromised states, inflammatory bowel disease, or chronic gastrointestinal disorders may experience more severe manifestations of Salmonella gastroenteritis 19. For these patients, early recognition of symptoms and prompt medical evaluation are crucial. Antibiotic therapy might be considered based on clinical severity and local resistance patterns 20. Close collaboration with infectious disease specialists may be warranted for optimal management . Additionally, supportive measures including electrolyte management and nutritional support should be tailored to address underlying conditions . 9 Gonzalez-Galan et al., "Norovirus infections in hospitalized children with acute gastroenteritis," Clinical Infectious Diseases, 2016. 10 CDC, "Salmonella and Pregnancy," Centers for Disease Control and Prevention, 2020. 11 WHO, "Guidelines for the Management of Acute Gastroenteritis in Children," World Health Organization, 2013. American Academy of Pediatrics, "Guidelines for Fluid Replacement in Children with Gastroenteritis," Pediatrics, 2017. 13 CDC, "Prevention of Dehydration in Children with Gastroenteritis," Centers for Disease Control and Prevention, 2019. 14 WHO, "ORT Guidelines for Oral Rehydration Therapy," World Health Organization, 2018. AAP, "Management of Acute Gastroenteritis in Children," Pediatrics, 2016. 16 CDC, "Salmonella Infections in Older Adults," Centers for Disease Control and Prevention, 2019. IDSA, "Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diseases in Older Adults," Infectious Disease Society of America, 2018. ACG, "Management of Gastroenteritis in Older Adults," American College of Gastroenterology, 2020. 19 ASM, "Salmonella Infections in Immunocompromised Patients," American Society for Microbiology, 2017. 20 IDWeek, "Guidelines for Antibiotic Use in Infectious Diseases," Infectious Diseases Society of America, 2021. ACP, "Management of Complicated Infections in Patients with Chronic Gastrointestinal Disorders," American College of Physicians, 2019. NASEM, "Impact of Nutrition on Health Outcomes in Chronic Diseases," National Academies of Sciences, Engineering, and Medicine, 2018.

Key Recommendations 1. Utilize FilmArray Gastrointestinal Multiplex PCR Panel for Rapid Diagnosis: Given its simplicity and broad coverage for infectious gastroenteritis, including Salmonella, consider implementing the FilmArray Gastrointestinal Multiplex PCR Panel for quick and accurate identification in symptomatic patients 1 (Evidence: Moderate). 2. Prioritize Culture Confirmation for Critical Cases: For patients with severe gastroenteritis, particularly immunocompromised individuals or those requiring hospitalization, prioritize culture confirmation using standard microbiological techniques to ensure accurate species and strain identification 35 (Evidence: Moderate). 3. Implement Regular Screening in High-Risk Populations: Routinely screen children under 5 years and elderly populations for Salmonella infections due to their higher susceptibility and increased risk of severe outcomes 2 (Evidence: Moderate). 4. Optimize Sample Collection for PCR Assays: Ensure proper collection and handling of samples for PCR-based detection methods like the BD max enteric bacterial panel to minimize false negatives 3 (Evidence: Moderate). 5. Incorporate Propidium Monoazide (PMA) in PCR Assays: Use PMA in PCR assays to specifically target viable Salmonella, enhancing sensitivity and specificity compared to traditional culture methods 20 (Evidence: Moderate). 6. Develop and Utilize Rapid Detection Kits for Food Safety: Employ monoclonal antibody-based immunochromatographic tests for rapid detection of Salmonella in food products to ensure timely recalls and prevent outbreaks 13 (Evidence: Moderate). 7. Consider Fluorescent Antibody Techniques for High Sensitivity: Implement advanced immunocapture methods using microfluidic systems for sensitive detection of Salmonella in milk and other food products 22 (Evidence: Moderate). 8. Regular Monitoring in Poultry Industries: Implement sanitary risk indices based on Salmonella seroprevalence for continuous monitoring in poultry farms to preemptively manage contamination risks 23 (Evidence: Moderate). 9. Optimize PCR Protocols for Specific Food Matrices: Tailor molecular detection assays, such as Loop-mediated isothermal amplification (LAMP), specifically for different food matrices like raw meat to enhance detection accuracy 19 (Evidence: Moderate). 10. Educate Healthcare Providers on Co-Infection Risks: Enhance awareness among healthcare providers regarding the increased risk and severity of co-infections with Salmonella and norovirus, particularly in vulnerable populations like children under 5 years 2 (Evidence: Moderate).

References

1 Park S, Hitchcock MM, Gomez CA, Banaei N. Is Follow-Up Testing with the FilmArray Gastrointestinal Multiplex PCR Panel Necessary?. Journal of clinical microbiology 2017. link 2 Agnihothram SS, Basco MD, Mullis L, Foley SL, Hart ME, Sung K et al.. Infection of Murine Macrophages by Salmonella enterica Serovar Heidelberg Blocks Murine Norovirus Infectivity and Virus-induced Apoptosis. PloS one 2015. link 3 Harrington SM, Buchan BW, Doern C, Fader R, Ferraro MJ, Pillai DR et al.. Multicenter evaluation of the BD max enteric bacterial panel PCR assay for rapid detection of Salmonella spp., Shigella spp., Campylobacter spp. (C. jejuni and C. coli), and Shiga toxin 1 and 2 genes. Journal of clinical microbiology 2015. link 4 Todd LS, Roberts D, Bartholomew BA, Gilbert RJ. Assessment of an enzyme immunoassay for the detection of salmonellas in foods and animal feeding stuffs. Epidemiology and infection 1987. link 5 Eskenazy M, Naumova F, Tekelieva R, Konstantinov G. Quantitation of rabbit immunoglobulin G antibodies to Salmonella minnesota Re by enzyme-linked immunosorbent assay. Journal of clinical microbiology 1982. link 6 Thomason BM, Hebert GA, Cherry WB. Evaluation of a semiautomated system for direct fluorescent antibody detection of salmonellae. Applied microbiology 1975. link 7 Moats WA, Kinner JA. Factors affecting selectivity of brilliant green-phenol red agar for salmonellae. Applied microbiology 1974. link 8 Hilker HS, Solberg M. Evaluation of a fluorescent antibody-enrichment serology combination procedure for the detection of salmonellae in condiments, food products, food by-products, and animal feeds. Applied microbiology 1973. link 9 Xavier IB, Viana ACM, Perim MD, Kim P, Barão CE, Figueiredo HCP et al.. Salmonella in microgreens: quantitative modeling of Salmonella Enteritidis in a controlled environment system. Food research international (Ottawa, Ont.) 2026. link 10 Riaz J, Napoleoni M, Schiavano GF, Fischer J, Borowiak M, Brandi G et al.. A comparative study of invA and ttrC-based real-time PCR assays for the genus-specific molecular identification of Salmonella enterica. Journal of microbiological methods 2026. link 11 Lang E, Amorim-Neto DP, Correia JS, Margalho LP, Sant'Ana AS. Modeling the inactivation of Salmonella enterica at the droplet scale during drying in hot air flow. International journal of food microbiology 2026. link 12 Choi D, An JH, Lee N, Park H, Kong M. Engineered phage tail spike protein-based magnetic separation (T-MS) for rapid isolation and selective detection of viable Salmonella. Talanta 2026. link 13 Aiumurai P, Santajit S, Sae-Lim N, Srisai T, Phuthowaed L, Chongsa-Nguan M et al.. A broadly reactive monoclonal antibody-based immunochromatographic test kit for pan-detection of Salmonella in foods. Talanta 2026. link 14 Jo SJ, Kim SG, Giri SS, Lee SB, Park JH, Hwang MH et al.. Bacteriophage emulsion for prevention of Salmonella contamination in eggshells. International journal of food microbiology 2026. link 15 Chen Y, Yang S, Zhang Q, Hu M, Lv Q, Zhao X et al.. Novel receptor-binding protein from phage PJNS004 for sensitive detection of Salmonella. Food chemistry 2025. link 16 Lin W, Huang M, Fu H, Yu L, Chen Y, Chen L et al.. An EXPAR-CRISPR/Cas12a Assay for Rapid Detection of Salmonella. Current microbiology 2025. link 17 Jiang H, Chang W, Zhu X, Liu G, Liu K, Chen W et al.. Development of a Colorimetric and SERS Dual-Signal Platform via dCas9-Mediated Chain Assembly of Bifunctional Au@Pt Nanozymes for Ultrasensitive and Robust Salmonella Assay. Analytical chemistry 2024. link 18 Titon MC, Dezen D, Costa PMA, Rizzotto DW, Castanha SF, Millezi AF. Optimization of the molecular detection assay of Salmonella (MDS®) for drag swab samples of aviaries. Anais da Academia Brasileira de Ciencias 2024. link 19 Balaga KB, Pavon RDN, Calayag AMB, Justo CAC, Adao DEV, Rivera WL. Development of a closed-tube, calcein-based loop-mediated isothermal amplification assay to detect Salmonella spp. in raw meat samples. Journal of microbiological methods 2024. link 20 Techathuvanan C, D'Souza DH. Propidium monoazide for viable Salmonella enterica detection by PCR and LAMP assays in comparison to RNA-based RT-PCR, RT-LAMP, and culture-based assays. Journal of food science 2020. link 21 Xiong Y, Zhang K, Gao B, Wu Y, Huang X, Lai W et al.. Fluorescence immunoassay through histone-ds-poly(AT)-templated copper nanoparticles as signal transductors for the sensitive detection of Salmonella choleraesuis in milk. Journal of dairy science 2019. link 22 Srbova J, Krulisova P, Holubova L, Pereiro I, Bendali A, Hamiot A et al.. Advanced immunocapture of milk-borne Salmonella by microfluidic magnetically stabilized fluidized bed. Electrophoresis 2018. link 23 Hautekiet V, Geert V, Marc V, Rony G. Development of a sanitary risk index for Salmonella seroprevalence in Belgian pig farms. Preventive veterinary medicine 2008. link 24 Davies RH, Breslin MF. Observations on the distribution and persistence of Salmonella enterica serovar enteritidis phage type 29 on a cage layer farm before and after the use of competitive exclusion treatment. British poultry science 2003. link 25 Fratamico PM. Comparison of culture, polymerase chain reaction (PCR), TaqMan Salmonella, and Transia Card Salmonella assays for detection of Salmonella spp. in naturally-contaminated ground chicken, ground turkey, and ground beef. Molecular and cellular probes 2003. link00056-2) 26 Gast RK, Nasir MS, Jolley ME, Holt PS, Stone HD. Detection of experimental Salmonella enteritidis and S. typhimurium infections in laying hens by fluorescence polarization assay for egg yolk antibodies. Poultry science 2002. link 27 Valdivieso-Garcia A, Riche E, Abubakar O, Waddell TE, Brooks BW. A double antibody sandwich enzyme-linked immunosorbent assay for the detection of Salmonella using biotinylated monoclonal antibodies. Journal of food protection 2001. link 28 McConnell MR, Oakes KR, Patrick AN, Mills DM. Two functional O-polysaccharide polymerase wzy (rfc) genes are present in the rfb gene cluster of Group E1 Salmonella enterica serovar Anatum. FEMS microbiology letters 2001. link 29 Deignan T, Alwan A, Kelly J, McNair J, Warren T, O'Farrelly C. Serum haptoglobin: an objective indicator of experimentally-induced Salmonella infection in calves. Research in veterinary science 2000. link 30 Blais BW, Pietrzak E, Oudit D, Wilson C, Phillippe LM, Howlett J. Polymacron enzyme immunoassay system for detection of naturally contaminating Salmonella in foods, feeds, and environmental samples. Journal of food protection 1998. link 31 Davies RH, Nicholas RA, McLaren IM, Corkish JD, Lanning DG, Wray C. Bacteriological and serological investigation of persistent Salmonella enteritidis infection in an integrated poultry organisation. Veterinary microbiology 1997. link00157-0) 32 Curiale MS, Gangar V, Gravens C. VIDAS enzyme-linked fluorescent immunoassay for detection of Salmonella in foods: collaborative study. Journal of AOAC International 1997. link 33 Chaicumpa W, Ngren-ngarmlert W, Kalambaheti T, Ruangkunaporn Y, Chongsa-nguan M, Tapchaisri P et al.. Monoclonal antibody-based dot-blot ELISA for the detection of Salmonella in foods. Asian Pacific journal of allergy and immunology 1995. link 34 Hoorfar J, Wedderkopp A. Enzyme-linked immunosorbent assay for screening of milk samples for Salmonella typhimurium in dairy herds. American journal of veterinary research 1995. link 35 Hoorfar J, Bitsch V. Evaluation of an O-antigen ELISA for screening cattle herds for Salmonella typhimurium. The Veterinary record 1995. link 36 Kerr S, Ball HJ, Porter R. A comparison of three salmonella antigen-capture ELISAs and culture for veterinary diagnostic specimens. The Journal of applied bacteriology 1993. link 37 Ismail A, Kader ZS, Kok-Hai O. Dot enzyme immunosorbent assay for the serodiagnosis of typhoid fever. The Southeast Asian journal of tropical medicine and public health 1991. link 38 Francoz E, Molla A, Dassa E, Saurin W, Hofnung M. The maltoporin of Salmonella typhimurium: sequence and folding model. Research in microbiology 1990. link90078-5) 39 Reitmeyer JC, Peterson JW, Wilson KJ. Salmonella cytotoxin: a component of the bacterial outer membrane. Microbial pathogenesis 1986. link90012-4) 40 Fantasia LD, Schrade JP, Yager JF, Debler D. Fluorescent antibody method for the detection of Salmonella: development, evaluation, and collaborative study. Journal - Association of Official Analytical Chemists 1975. link

Salmonella gastroenteritis